La #experienciapaciente de personas con #esclerosismultiple como fuente de evidencia del mundo real en investigación clínica. Es ciencia https://t.co/SJNs7n47ow
La #experienciapaciente de personas con #esclerosismultiple como fuente de evidencia del mundo real en investigación clínica. Es ciencia https://t.co/WkbYQ4gFgL
#realworld #patientexperience of #fingolimod + #dimethylfumarate for #multiplesclerosis @Paperity PDF: https://t.co/ir7pa78nHl via @Paperity
RT @PaulLikeMe: Just in time for #ECTRIMS2016! Real-world experience of Gilenya & Tecfidera in MS by @patientslikeme https://t.co/MOlyhnpT…
RT @PaulLikeMe: Just in time for #ECTRIMS2016! Real-world experience of Gilenya & Tecfidera in MS by @patientslikeme https://t.co/MOlyhnpT…
RT @PaulLikeMe: Just in time for #ECTRIMS2016! Real-world experience of Gilenya & Tecfidera in MS by @patientslikeme https://t.co/MOlyhnpT…
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis. https://t.co/2ezmxLiCVO
The real-world patient experience of fingolimod and dimethyl fumarate for multiple sclerosis. https://t.co/OvZJOmeMMw
Just in time for #ECTRIMS2016! Real-world experience of Gilenya & Tecfidera in MS by @patientslikeme https://t.co/MOlyhnpTNq #OA